Научная литература
booksshare.net -> Добавить материал -> Медицина -> Джордж А.Г. -> "Анестезия и педиатрия" -> 95

Анестезия и педиатрия - Джордж А.Г.

Джордж А.Г. Анестезия и педиатрия — М.: Медицина, 2003. — 1192 c.
ISBN 5-225-03821-2
Скачать (прямая ссылка): anesteziyavpedeatrii2003.djvu
Предыдущая << 1 .. 89 90 91 92 93 94 < 95 > 96 97 98 99 100 101 .. 1012 >> Следующая

121. Rosenberg H, Fletcher JE: Masseter muscle rigidity and malignant hyperthermia susceptibility. Anesth Analg 65:161, 1986
122. Omdahl G, Stenberg K: Myotonic human musculature: stimulation with depolarizing agents. Acta Med Scand 172:3, 1962
123. Lesseli S, Kuwabara T, Feldman RG: Myopathy and succinylcholine sensitivity. Am J Ophthalmol 68:789, 1969
124. Mambo NC, Silver MD, McLaughlin PRet al: Malignant hyperthermia susceptibility. A light and electron microscopic study of endomyocardial biopsy specimens from nine patients. Hum Pathol 11:381, 1980
125. Huckell VF, Staniloff HM, McLaughlin PR et al: Cardiovascular manifestations of normothermic malignant hypeithermia. p. 373. In Aldrete JA, Britt BA (eds): Malignant Hyperthermia. Gmnc & Stratton, New York. 1977
126. Huckell VF, Staniloff HM, Britt BA, Morch JE: Electrocardiographic abnormalities associated with malignant hyperthermia susceptibility. J Electrocardiol 15:137, 1982
104 Анестезия в педиатрии
127. Lucke JN, Hall GM, Lister D: Porcine malignant hyperthermia. I: Metabolic and physiological changes. Br J Anaesth 48:297, 1976
128. Dunn CM, Maltry DE, Eggets GWN Jr: Value of mass spectrometry in early diagnosis of malignant hyperthermia |ietter|. Anesthesiology 63:333, 1985
129. Baudendistel L, Goudsouzian N, Cote C, Strafford M: End-tidal CO; monitoring- Its use in the diagnosis and management of malignant hyperthermia. Anaesthesia 39:1000, 1984
130. Hall GM, Lucke JN, Orchard С et a!: Effect of dantrolene on leg metabolism in porcine malignant hyperthermia. Anaesthesia 37:1167, 1982
131. Gronert GA, Milde JH, Theye RA: Dantrolene in porcine malignant hyperthermia. Anesthesiology 44:488, 1976
132. Gronert GA, Milde JH, Theye RA: Porcine malignant hyperthermia induced by halothane aud succinylcholine: failure of treatment with procaine or procainamide. Anesthesiology 44:124, 1976
133. Hall GM, Lucke JN, Lovell R, Lister D: Porcine malignant hyperthermia. VII: Hepatic metabolism. Br J Anaesth 52:11, 1980
134. Gronert GA, Theye RA, Milde JH, Tinker JH: Catecholamine stimulation of myocardial oxygen consumption in porcine malignant hyperthermia. Anesthesiology 49, 1978
135. Artru AA, Gronert GA: Cerebral metabolism during porcine malignant hyperthermia. Anesthesiology 53:121, |980
136. Huckell VF, Staniloff HM, Britt BA et al: Cardiac man* ifestations of malignant hyperthermia susceptibility. Circulation 58:916, 1978
137. Falk E, Simonsen J: The histology of myocardium in malignant hyperthermia: a preliminary report of 11 cases. Forensic Sci 13:211, 1979
138. Fenoglio JJ Jr, Irey NS: Myocardial changes in malignant hyperthermia. Am J Pathol 89:51, 1977
139. Denborough MA, Galloway GJ, Hopkinson КС: Malignant hyperpyrexia and sudden infant death. Lancet 2:1068, 1982
140. Peterson DR, Davis N: Sudden infant death syndrome and malignant hyperthermia diathesis. Aust Paediatr J 22(sup-pl l):33, 1986
141. Ryan JF, Donlon JV, Malt RAetal: Cardiopulmonary bypass in the treatment of malignant hyperthermia. N Engl J Med 290:1121, 1974
142. Britt BA: Section three: malignant hyperthermia, p 291. In Orkin FA, Cooperman LH (eds). Complications in Anesthesiology. JB Ljppincott, Philadelphia, 1983, p. 291
143. Roberts JT, Burt T, Gyulaj L et al: Dalayed recovery of intracellular skeletal muscle pH measured by phophorus-
31 nuclear magnetic resonance in malignant hyperthermic swine with partial to full recovery of arterial pH following treatment with sodium dantrolene. Anesthesiology 63:A272, 1985
144. Rosenberg H: Trismus is not trivial {letter). Anesthesiology 67:453, 1987
|45. Gronert G: Management of patients in whom trismus occurs following succinylcholine (letter). Anesthesiology 68:653, 1988
146. Yentis SM, Levine MF, Hartley EJ: Should all children with suspected or confirmed malignant hyperthermia susceptibility be admitted after surgery? A 10-year review. Anesth Analg 75:345, 1992
147. Tang TT, Oechler HW, Siker D et al: Anesthesia-induced tbabdomyolysis in infants with unsuspected Duchenne dystrophy. Acta Paediatr 81:716, 1992
148. Austin K.L, Denborough MA: Drug treatment of malignant hyperpyrexia. Anaesth Intensive Care 5:207, 1977
149. Britt BA, Kwong F, Endrenyi L: Management of malignant hyperthermia susceptible (MHS) patients — a review, p. 63. in Henschei ED (ed): Malignant Hyperthermia: Current Concepts. Appleton—Century—Crofts, East Norwalk, CT, 1977
150. Flewellen EH, Nelson ТЕ: Dantrolene dose response in malignant hyperthermia-susceptible (M HS) swine: method to obtain prophylaxis and therapeusis. Anesthesiology 52:303, 1980
151. Flewellen EH, Nelson ТЕ, Jones WP et al: Dantrolene dose response in awake man: implications for management of malignant hyperthermia. Anesthesiology 59:275, 1983
152. Lopez JR, Alamo L, Jones D et al: [Ca’ ]i reduction in skeletal muscle by dantrolene sodium prevents malignant hyperthermia. Anesthesiology 63:A273, 1985
153. Kolb ME, Home ML, MarU R: Dantrolene in human malignant hyperthermia. Anesthesiology 56:254, 1982
Предыдущая << 1 .. 89 90 91 92 93 94 < 95 > 96 97 98 99 100 101 .. 1012 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed